Lipella Pharmaceuticals Inc.
  1. Companies
  2. Lipella Pharmaceuticals Inc.
  3. News
  4. Announcing Radiation (and Hemorrhagic) ...

Announcing Radiation (and Hemorrhagic) Cystitis Patient Registry: for people affected by pelvic radiation during cancer treatment.

SHARE
May. 9, 2022

Pittsburgh, PA – (May 9, 2022) – Lipella Pharmaceuticals, Inc. is announcing the Radiation Cystitis Patient Registry, an on-line patient registry program for people who are affected by pelvic radiation exposure, including survivors of pelvic cancers, such as prostate, uterine, cervical and colon cancer.